Mucosal Vaccines, Sterilizing Immunity, and the Future of SARS-CoV-2 Virulence
Mucosal Vaccines, Sterilizing Immunity, and the Future of SARS-CoV-2 Virulence
About this item
Full title
Author / Creator
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
Sterilizing immunity after vaccination is desirable to prevent the spread of infection from vaccinees, which can be especially dangerous in hospital settings while managing frail patients. Sterilizing immunity requires neutralizing antibodies at the site of infection, which for respiratory viruses such as SARS-CoV-2 implies the occurrence of neutra...
Alternative Titles
Full title
Mucosal Vaccines, Sterilizing Immunity, and the Future of SARS-CoV-2 Virulence
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_852a3c79938849e9ba1bfe2d426a6cd3
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_852a3c79938849e9ba1bfe2d426a6cd3
Other Identifiers
ISSN
1999-4915
E-ISSN
1999-4915
DOI
10.3390/v14020187
